These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31758594)

  • 1. Incorporating retesting outcomes for estimation of disease prevalence.
    Zhang W; Liu A; Li Q; Albert PS
    Stat Med; 2020 Mar; 39(6):687-697. PubMed ID: 31758594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.
    Meisner J; Roberts DA; Rodriguez P; Sharma M; Newman Owiredu M; Gomez B; de Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Farid S; Essajee S; Jamil MS; Baggaley R; Johnson C; Drake AL
    J Int AIDS Soc; 2021 Apr; 24(4):e25686. PubMed ID: 33787064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group testing regression model estimation when case identification is a goal.
    Zhang B; Bilder CR; Tebbs JM
    Biom J; 2013 Mar; 55(2):173-89. PubMed ID: 23401252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of the cost of different methods of retesting chlamydia positive individuals in England.
    Looker KJ; Buitendam E; Woodhall SC; Hollis E; Ong KJ; Saunders JM; Dunbar K; Turner KME
    BMJ Open; 2019 Mar; 9(3):e024828. PubMed ID: 30904855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in the screening for Chlamydia trachomatis: a review.
    Kohl KS; Markowitz LE; Koumans EH
    Obstet Gynecol Clin North Am; 2003 Dec; 30(4):637-58. PubMed ID: 14719842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Pooled Testing for Estimating the Prevalence of Multiple Diseases.
    Warasi MS; Hungerford LL; Lahmers K
    J Agric Biol Environ Stat; 2022; 27(4):713-727. PubMed ID: 35975123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status.
    Garrison LP; Lalla D; Brammer M; Babigumira JB; Wang B; Perez EA
    Cancer; 2013 Sep; 119(17):3113-22. PubMed ID: 23775560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy "Test-and-Offer" Era.
    Eaton JW; Johnson CC; Gregson S
    Clin Infect Dis; 2017 Aug; 65(3):522-525. PubMed ID: 28444206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial.
    Smith KS; Kaldor JM; Hocking JS; Jamil MS; McNulty AM; Read P; Bradshaw CS; Chen MY; Fairley CK; Wand H; Worthington K; Blake S; Knight V; Rawlinson W; Saville M; Tabrizi SN; Garland SM; Donovan B; Guy R
    BMC Public Health; 2016 Jan; 16():83. PubMed ID: 26822715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost implications of HIV retesting for verification in Africa.
    Lasry A; Kalou MB; Young PR; Rurangirwa J; Parekh B; Behel S
    PLoS One; 2019; 14(7):e0218936. PubMed ID: 31260467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study.
    Rodriguez PJ; Roberts DA; Meisner J; Sharma M; Owiredu MN; Gomez B; Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Barr-Dichiara M; Jamil MS; Baggaley R; Johnson C; Taylor MM; Drake AL
    Lancet Glob Health; 2021 Jan; 9(1):e61-e71. PubMed ID: 33227254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother-to-child HIV transmission (EMTCT) efforts.
    Drake AL; Thomson KA; Quinn C; Newman Owiredu M; Nuwagira IB; Chitembo L; Essajee S; Baggaley R; Johnson CC
    J Int AIDS Soc; 2019 Apr; 22(4):e25271. PubMed ID: 30958644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing HIV testing services in sub-Saharan Africa: cost and performance of verification testing with HIV self-tests and tests for triage.
    Eaton JW; Terris-Prestholt F; Cambiano V; Sands A; Baggaley RC; Hatzold K; Corbett EL; Kalua T; Jahn A; Johnson CC
    J Int AIDS Soc; 2019 Mar; 22 Suppl 1(Suppl Suppl 1):e25237. PubMed ID: 30907507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and challenges when pooling milk samples using ELISA.
    Græsbøll K; Andresen LO; Halasa T; Toft N
    Prev Vet Med; 2017 Apr; 139(Pt B):93-98. PubMed ID: 27717600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda.
    Chamie G; Ndyabakira A; Marson KG; Emperador DM; Kamya MR; Havlir DV; Kwarisiima D; Thirumurthy H
    PLoS One; 2020; 15(5):e0233600. PubMed ID: 32470089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost.
    Lyng GD; Sheils NE; Kennedy CJ; Griffin DO; Berke EM
    PLoS One; 2021; 16(3):e0248783. PubMed ID: 33764982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal retesting configurations for hierarchical group testing.
    Black MS; Bilder CR; Tebbs JM
    J R Stat Soc Ser C Appl Stat; 2015 Aug; 64(4):693-710. PubMed ID: 26166904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of retesting BRCA negative patients using multigene panels.
    Yadav S; Reeves A; Campian S; Paine A; Zakalik D
    Fam Cancer; 2017 Jul; 16(3):319-328. PubMed ID: 27878467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and predictors of HIV positivity and time since last test at voluntary counselling and testing encounters among adults in Kilifi, Kenya, 2006-2017.
    Mugo PM; Agutu CA; Wahome E; Juma M; Nzioka J; Mohamed K; Mumba T; Shally M; Fauz I; Omar A; Rinke de Wit TF; van der Elst EM; Graham SM; Sanders EJ
    Wellcome Open Res; 2019; 4():127. PubMed ID: 33884308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.